Hemostasis at the ovary and its influence on postoperative fertility course N83.0 N83.2 N83.1 N80.1
Conditions
Interventions
Group 1: After resection of the ovarian cyst, the wound bed is treated with 4DryField powder to achieve hemostasis
Group 2: After resection of the ovarian cyst, the wound bed is treated by bipolar ele
Sponsors
Universitätsklinikum Bonn
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Uni- or bilateral ovarian cyst resection, adnexectomy, or salpingectomy • Written consent to participate in the study • Preoperative AMH concentration = 2.0 µg/l
Exclusion criteria
Exclusion criteria: • Pregnant patients • Patients for whom no hemostasis measures are required during surgery • Patients with manifest tubo-ovarian abscess • Patients with a coagulation disorder • Patients with known intolerance to plant starch or 4DryField • Patients for whom standard blood samples cannot be taken at the required times
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relative postoperative Anti-Müllerian Hormone (AMH) concentration at the time of suture removal (calculated as the difference from the preoperative value) | — |
Secondary
| Measure | Time frame |
|---|---|
| - Relative postoperative AMH concentration on postoperative days 1 and 2 (calculated as the difference from the preoperative value) - Rate of postoperative complications - Course of Hb/Hct concentration - Postoperative development of inflammatory parameters: leukocytes, CRP, PCT, IL-6, and body temperature | — |
Countries
Germany
Contacts
Public ContactAlexander Mustea
Universitätsklinikum Bonn
Outcome results
None listed